Research News

Join WhatsApp Channel

- Read more about Gene-editing technique could treat muscular dystrophy
A gene-editing technique has shown promise in treating Duchenne muscular dystrophy (DMD), the most common and severe form of muscular dystrophy among boys which is characterised by progressive muscle degeneration and weakness.
- Read more about Safer polio vaccine strains for post-eradication era developed
Researchers have developed new polio vaccine strains that is particularly suitable for a post-eradication era as these strains appear both effective and unable to cause disease after accidental release.
- Read more about Cadila clarifies US regulatory warning on Gujarat units
Pharma major Cadila Healthcare on Thursday clarified that products from its Moraiya and Ahmedabad plants in Gujarat were safe in the market and effective.
- Read more about Vitamin D could treat people with multiple sclerosis
Taking a high dose of vitamin D could be an inexpensive and easy way to treat people with multiple sclerosis (MS), an autoimmune disorder that affects the brain and spinal chord, suggests promising new research.
- Read more about Gastroenterology institute uses new technique to cure acidity
The city-based Asian Institute of Gastroenterology on Wednesday claimed that it successfully used a new technique for treatment of gastro-esophageal reflux disease (GERD), usually termed as acidity.
- Read more about Drugs delivered as liquid salt through skin reduces toxicity
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity, say researchers, including one of Indian-origin. A novel formulation of the drug propranolol as a liquid salt enables delivery through skin with reduced toxicity, the findings showed.

[adsense:336x280:8701650588]
- Read more about Daiichi Sankyo Korea & Daewoong Pharmaceutical Signs Agreement to co market LIXIANA® in South Korea
Daiichi Sankyo Company, Limited announced that its wholly owned subsidiary, Daiichi Sankyo Korea Co., Ltd. (hereafter “DSKR;” headquarters: Jongno-gu, Seoul, South Korea), and Daewoong Pharmaceutical Co., Ltd. (hereafter “Daewoong Pharmaceutical;” headquarter: Gangnam-gu, Seoul, South Korea) have signed an agreement for the co-promotion of the oral, once-daily anti-coagulant, LIXIANA® (generic name: edoxaban).
- Read more about New breast cancer drug may combat other cancers too
A new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, new research has found.
- Read more about Guinea declared Ebola-free
The World Health Organisation on Tuesday declared the end of the Ebola outbreak in the West African nation of Guinea, two years after the beginning of the epidemic.
- Read more about New antibody may help old people regain muscle power
A newly created antibody could treat the decline in muscle mass and power associated with ageing, show results of a phase-two trial by an international research team.